166 related articles for article (PubMed ID: 11441074)
1. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase.
Grohmann U; Fallarino F; Bianchi R; Belladonna ML; Vacca C; Orabona C; Uyttenhove C; Fioretti MC; Puccetti P
J Immunol; 2001 Jul; 167(2):708-14. PubMed ID: 11441074
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells.
Grohmann U; Fallarino F; Silla S; Bianchi R; Belladonna ML; Vacca C; Micheletti A; Fioretti MC; Puccetti P
J Immunol; 2001 Jan; 166(1):277-83. PubMed ID: 11123303
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentiation of the CD8 alpha+ subset.
Grohmann U; Bianchi R; Belladonna ML; Silla S; Fallarino F; Fioretti MC; Puccetti P
J Immunol; 2000 Aug; 165(3):1357-63. PubMed ID: 10903738
[TBL] [Abstract][Full Text] [Related]
4. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.
Grohmann U; Bianchi R; Orabona C; Fallarino F; Vacca C; Micheletti A; Fioretti MC; Puccetti P
J Immunol; 2003 Sep; 171(5):2581-7. PubMed ID: 12928409
[TBL] [Abstract][Full Text] [Related]
5. IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells.
Stober D; Schirmbeck R; Reimann J
J Immunol; 2001 Jul; 167(2):957-65. PubMed ID: 11441104
[TBL] [Abstract][Full Text] [Related]
6. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
Kelleher M; Beverley PC
J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
[TBL] [Abstract][Full Text] [Related]
8. Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation.
Bianchi R; Grohmann U; Vacca C; Belladonna ML; Fioretti MC; Puccetti P
J Immunol; 1999 Sep; 163(5):2517-21. PubMed ID: 10452988
[TBL] [Abstract][Full Text] [Related]
9. Differential requirement for the CD40-CD154 costimulatory pathway during Th cell priming by CD8 alpha+ and CD8 alpha- murine dendritic cell subsets.
Yasumi T; Katamura K; Yoshioka T; Meguro TA; Nishikomori R; Heike T; Inobe M; Kon S; Uede T; Nakahata T
J Immunol; 2004 Apr; 172(8):4826-33. PubMed ID: 15067060
[TBL] [Abstract][Full Text] [Related]
10. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells.
Kaliński P; Schuitemaker JH; Hilkens CM; Wierenga EA; Kapsenberg ML
J Immunol; 1999 Mar; 162(6):3231-6. PubMed ID: 10092774
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant.
Orabona C; Belladonna ML; Vacca C; Bianchi R; Fallarino F; Volpi C; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2005 Jun; 174(11):6582-6. PubMed ID: 15905495
[TBL] [Abstract][Full Text] [Related]
12. Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.
Kim YJ; Park SJ; Broxmeyer HE
J Immunol; 2011 Sep; 187(5):2291-301. PubMed ID: 21795591
[TBL] [Abstract][Full Text] [Related]
13. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets.
Hochrein H; Shortman K; Vremec D; Scott B; Hertzog P; O'Keeffe M
J Immunol; 2001 May; 166(9):5448-55. PubMed ID: 11313382
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
[TBL] [Abstract][Full Text] [Related]
15. IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo.
Grohmann U; Bianchi R; Belladonna ML; Vacca C; Silla S; Ayroldi E; Fioretti MC; Puccetti P
J Immunol; 1999 Sep; 163(6):3100-5. PubMed ID: 10477575
[TBL] [Abstract][Full Text] [Related]
16. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
Bianchi R; Grohmann U; Belladonna ML; Silla S; Fallarino F; Ayroldi E; Fioretti MC; Puccetti P
J Immunol; 1996 Aug; 157(4):1589-97. PubMed ID: 8759743
[TBL] [Abstract][Full Text] [Related]
17. CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.
Terheyden P; Straten P; Bröcker EB; Kämpgen E; Becker JC
J Immunol; 2000 Jun; 164(12):6633-9. PubMed ID: 10843723
[TBL] [Abstract][Full Text] [Related]
18. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.
Gao JX; Madrenas J; Zeng W; Cameron MJ; Zhang Z; Wang JJ; Zhong R; Grant D
Immunology; 1999 Oct; 98(2):159-70. PubMed ID: 10540214
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Effects of Interferon-γ and Vitamin D
Švajger U; Rožman PJ
Front Immunol; 2019; 10():2627. PubMed ID: 31798578
[TBL] [Abstract][Full Text] [Related]
20. Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells.
Bacher N; Graulich E; Jonuleit H; Grabbe S; Steinbrink K
PLoS One; 2011; 6(7):e22763. PubMed ID: 21818385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
